Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Geron (GERN) Cash & Equivalents (2016 - 2025)

Geron (GERN) has disclosed Cash & Equivalents for 16 consecutive years, with $53.9 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 31.75% to $53.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $53.9 million through Dec 2025, down 31.75% year-over-year, with the annual reading at $53.9 million for FY2025, 31.75% down from the prior year.
  • Cash & Equivalents hit $53.9 million in Q4 2025 for Geron, up from $1.9 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $189.8 million in Q1 2024 to a low of $363000.0 in Q1 2021.
  • Historically, Cash & Equivalents has averaged $31.2 million across 5 years, with a median of $1.9 million in 2024.
  • Biggest five-year swings in Cash & Equivalents: tumbled 99.36% in 2022 and later soared 30882.69% in 2023.
  • Year by year, Cash & Equivalents stood at $364000.0 in 2021, then changed by 0.0% to $364000.0 in 2022, then surged by 206.32% to $1.1 million in 2023, then soared by 6986.64% to $79.0 million in 2024, then tumbled by 31.75% to $53.9 million in 2025.
  • Business Quant data shows Cash & Equivalents for GERN at $53.9 million in Q4 2025, $1.9 million in Q3 2025, and $1.9 million in Q2 2025.